Xtant Medical Holdings Stock Analysis
XTNT Stock | USD 0.40 0.01 2.44% |
Xtant Medical Holdings is undervalued with Real Value of 0.63 and Target Price of 1.35. The main objective of Xtant Medical stock analysis is to determine its intrinsic value, which is an estimate of what Xtant Medical Holdings is worth, separate from its market price. There are two main types of Xtant Medical's stock analysis: fundamental analysis and technical analysis.
The Xtant Medical stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Xtant Medical is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Xtant Stock trading window is adjusted to America/New York timezone.
Xtant |
Xtant Stock Analysis Notes
About 65.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.22. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Xtant Medical Holdings recorded a loss per share of 0.13. The entity last dividend was issued on the 14th of February 2018. The firm had 1:12 split on the 14th of February 2018. Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. Xtant Medical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 116 people. For more information please call Sean Browne at 406 388 0480 or visit https://www.xtantmedical.com.Xtant Medical Quarterly Total Revenue |
|
Xtant Medical Holdings Investment Alerts
Xtant Medical generated a negative expected return over the last 90 days | |
Xtant Medical has some characteristics of a very speculative penny stock | |
Xtant Medical has high historical volatility and very poor performance | |
Xtant Medical has high likelihood to experience some financial distress in the next 2 years | |
Xtant Medical Holdings currently holds about 16.5 M in cash with (9.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
Xtant Medical has a poor financial position based on the latest SEC disclosures | |
Roughly 65.0% of the company outstanding shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: lker Biskvi Sanayi Leads This Trio Of Stocks That May Be Underestimated By The Market |
Xtant Medical Holdings Upcoming and Recent Events
5th of March 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Xtant Largest EPS Surprises
Earnings surprises can significantly impact Xtant Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-08-08 | 2024-06-30 | -0.02 | -0.03 | -0.01 | 50 | ||
2024-04-01 | 2024-03-31 | -0.02 | -0.03 | -0.01 | 50 | ||
2024-02-13 | 2023-12-31 | -0.02 | -0.03 | -0.01 | 50 |
Xtant Medical Thematic Classifications
In addition to having Xtant Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
DrugsDrug manufacturing and delivery |
Xtant Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 55.6 M.Xtant Profitablity
The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.1.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.01 | 0.01 | |
Return On Capital Employed | (0.15) | (0.15) | |
Return On Assets | 0.01 | 0.01 | |
Return On Equity | 0.01 | 0.01 |
Management Efficiency
Xtant Medical Holdings has return on total asset (ROA) of (0.1058) % which means that it has lost $0.1058 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0877) %, meaning that it created substantial loss on money invested by shareholders. Xtant Medical's management efficiency ratios could be used to measure how well Xtant Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Xtant Medical's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.01 in 2024, whereas Return On Capital Employed is likely to drop (0.15) in 2024. Change To Liabilities is likely to gain to about 1.9 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 16 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.43 | 0.45 | |
Tangible Book Value Per Share | 0.29 | 0.30 | |
Enterprise Value Over EBITDA | 30.03 | 31.54 | |
Price Book Value Ratio | 2.62 | 2.49 | |
Enterprise Value Multiple | 30.03 | 31.54 | |
Price Fair Value | 2.62 | 2.49 | |
Enterprise Value | 152.4 M | 107.5 M |
Leadership effectiveness at Xtant Medical Holdings is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (0.1) | Profit Margin (0.03) | Beta 0.385 | Return On Assets (0.11) | Return On Equity (0.09) |
Technical Drivers
As of the 30th of November, Xtant Medical maintains the Standard Deviation of 5.48, mean deviation of 3.25, and Market Risk Adjusted Performance of (1.46). Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xtant Medical Holdings, as well as the relationship between them.Xtant Medical Holdings Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Xtant Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Xtant Medical Holdings. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Xtant Medical Holdings Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Xtant Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Xtant Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Xtant Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sean Browne over a month ago Disposition of 105442 shares by Sean Browne of Xtant Medical at 0.59 subject to Rule 16b-3 | ||
Sean Browne over three months ago Disposition of 10606 shares by Sean Browne of Xtant Medical at 0.6 subject to Rule 16b-3 | ||
Sean Browne over six months ago Disposition of 80000 shares by Sean Browne of Xtant Medical at 0.6751 subject to Rule 16b-3 | ||
Michael Eggenberg over six months ago Acquisition by Michael Eggenberg of 46784775 shares of Xtant Medical at 1.07 subject to Rule 16b-3 | ||
Sean Browne over six months ago Acquisition by Sean Browne of 731632 shares of Xtant Medical subject to Rule 16b-3 | ||
Scott Neils over six months ago Acquisition by Scott Neils of 177551 shares of Xtant Medical subject to Rule 16b-3 | ||
Vizirgianakis Stavros G over a year ago Acquisition by Vizirgianakis Stavros G of 217770 shares of Xtant Medical subject to Rule 16b-3 |
Xtant Medical Outstanding Bonds
Xtant Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Xtant Medical Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Xtant bonds can be classified according to their maturity, which is the date when Xtant Medical Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
XEROX HLDGS P Corp BondUS98421MAB28 | View | |
XEROX HLDGS P Corp BondUS98421MAA45 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
US98420EAB11 Corp BondUS98420EAB11 | View |
Xtant Medical Predictive Daily Indicators
Xtant Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Xtant Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Xtant Medical Forecast Models
Xtant Medical's time-series forecasting models are one of many Xtant Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Xtant Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Xtant Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Xtant Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Xtant shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Xtant Medical. By using and applying Xtant Stock analysis, traders can create a robust methodology for identifying Xtant entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.01) | (0.01) | |
Operating Profit Margin | (0.11) | (0.12) | |
Net Profit Margin | 0.01 | 0.01 | |
Gross Profit Margin | 0.61 | 0.49 |
Current Xtant Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Xtant analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Xtant analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
1.35 | Strong Buy | 2 | Odds |
Most Xtant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Xtant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Xtant Medical Holdings, talking to its executives and customers, or listening to Xtant conference calls.
Xtant Stock Analysis Indicators
Xtant Medical Holdings stock analysis indicators help investors evaluate how Xtant Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Xtant Medical shares will generate the highest return on investment. By understating and applying Xtant Medical stock analysis, traders can identify Xtant Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 20.5 M | |
Long Term Debt | 17.2 M | |
Common Stock Shares Outstanding | 126.8 M | |
Total Stockholder Equity | 51.3 M | |
Tax Provision | -2.3 M | |
Property Plant And Equipment Net | 10.2 M | |
Cash And Short Term Investments | 5.7 M | |
Cash | 5.7 M | |
Accounts Payable | 7.1 M | |
Net Debt | 17.8 M | |
50 Day M A | 0.554 | |
Total Current Liabilities | 23 M | |
Other Operating Expenses | 101.5 M | |
Non Current Assets Total | 27.7 M | |
Non Currrent Assets Other | 141 K | |
Stock Based Compensation | 2.7 M |
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.